FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues

被引:117
|
作者
Cook, JR
Lee, JH
Yang, ZH
Krause, CD
Herth, N
Hoffmann, R
Pestka, S
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[2] Univ Leipzig, Ctr Biotechnol & Biomed, Fac Chem & Mineral, D-04103 Leipzig, Germany
[3] PBL Biomed Labs, Piscataway, NJ 08854 USA
[4] Canc Inst New Jersey, New Brunswick, NJ 08903 USA
关键词
PRMT; protein arginine methyltransferase; type II; symmetric dimethylarginine; immunolocalization; structure modeling; methylation; FBXO11; FLJ12673; F-box; zinc finger; beta-propeller;
D O I
10.1016/j.bbrc.2006.01.167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have identified a protein, FLJ12673 or FBXO 11, that contains domains characteristically present in protein arginine methyltransferases (PRMTs). Immuno-purified protein expressed from one of the four splice variants in HeLa cells and in Escherichia coli exhibited methyltransferase activity. Monomethylarginine, symmetric, and asymmetric dimethylarginine (SDMA, ADMA) were formed on arginine residues. Accordingly, we have designated the protein PRMT9. PRMT9 is the third member of the PRMT family that forms SDMA modifications in proteins. Structurally, this protein is distinct from all other known PRMTs implying that convergent evolution allowed this protein to develop the ability to methylate arginine residues and evolved elements conserved in PRMTs to accomplish this. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:472 / 481
页数:10
相关论文
共 50 条
  • [21] The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4
    Mallappa, Chandrashekara
    Hu, Yu-Jie
    Shamulailatpam, Priscilla
    Tae, Sookil
    Sif, Said
    Imbalzano, Anthony N.
    NUCLEIC ACIDS RESEARCH, 2011, 39 (04) : 1243 - 1255
  • [22] Specific regional distribution of protein arginine methyltransferase 8 (PRMT8) in the mouse brain
    Taneda, Tsuya
    Miyata, Shingo
    Kousaka, Aoi
    Inoue, Kiyoshi
    Koyama, Yoshihisa
    Mori, Yasutake
    Tohyama, Masaya
    BRAIN RESEARCH, 2007, 1155 : 1 - 9
  • [23] Comparative Monomethylarginine Proteomics Suggests that Protein Arginine Methyltransferase 1 (PRMT1) is a Significant Contributor to Arginine Monomethylation in Toxoplasma gondii
    Yakubu, Rama R.
    de Monerri, Natalie C. Silmon
    Nieves, Edward
    Kim, Kami
    Weiss, Louis M.
    MOLECULAR & CELLULAR PROTEOMICS, 2017, 16 (04) : 567 - 580
  • [24] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
    Lin, Hong
    Wang, Min
    Zhang, Yang W.
    Tong, Shuilong
    Leal, Raul A.
    Shetty, Rupa
    Vaddi, Kris
    Luengo, Juan I.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038
  • [25] Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6)
    Yang, Hongling
    Zhang, Qiangsheng
    Zhou, Shuyan
    Hu, Zuli
    Tang, Qing
    Li, Zulong
    Feng, Qiang
    Yu, Luoting
    BIOORGANIC CHEMISTRY, 2024, 148
  • [26] Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation
    Wang, Chen
    Jiang, Hao
    Jin, Jia
    Xie, Yiqian
    Chen, Zhifeng
    Zhang, Hao
    Lian, Fulin
    Liu, Yu-Chih
    Zhang, Chenhua
    Ding, Hong
    Chen, Shijie
    Zhang, Naixia
    Zhang, Yuanyuan
    Jiang, Hualiang
    Chen, Kaixian
    Ye, Fei
    Yao, Zhiyi
    Luo, Cheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (21) : 8888 - 8905
  • [27] Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review
    Feustel, Kavanya
    Falchook, Gerald S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (03) : 58 - 67
  • [28] The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma
    Holmes, Brent
    Benavides-Serrato, Angelica
    Saunders, Jacquelyn T.
    Landon, Kenna A.
    Schreck, Adam J.
    Nishimura, Robert N.
    Gera, Joseph
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 11 - 22
  • [29] Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
    Yan, Fengting
    Alinari, Lapo
    Lustberg, Mark E.
    Martin, Ludmila Katherine
    Cordero-Nieves, Hector M.
    Banasavadi-Siddegowda, Yeshavanth
    Virk, Selene
    Barnholtz-Sloan, Jill
    Bell, Erica Hlavin
    Wojton, Jeffrey
    Jacob, Naduparambil K.
    Chakravarti, Arnab
    Nowicki, Michal O.
    Wu, Xin
    Lapalombella, Rosa
    Datta, Jharna
    Yu, Bo
    Gordon, Kate
    Haseley, Amy
    Patton, John T.
    Smith, Porsha L.
    Ryu, John
    Zhang, Xiaoli
    Mo, Xiaokui
    Marcucci, Guido
    Nuovo, Gerard
    Kwon, Chang-Hyuk
    Byrd, John C.
    Chiocca, E. Antonio
    Li, Chenglong
    Sif, Said
    Jacob, Samson
    Lawler, Sean
    Kaur, Balveen
    Baiocchi, Robert A.
    CANCER RESEARCH, 2014, 74 (06) : 1752 - 1765
  • [30] Tyrosine 87 is vital for the activity of human protein arginine methyltransferase 3 (PRMT3)
    Handrkova, Helena
    Petrak, Jiri
    Halada, Petr
    Pospisilova, Dagmar
    Cmejla, Radek
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (02): : 277 - 282